HEADER TRANSFERASE/TRANSFERASE INHIBITOR 11-JUN-01 1JCS TITLE CRYSTAL STRUCTURE OF RAT PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH TITLE 2 THE PEPTIDE SUBSTRATE TKCVFM AND AN ANALOG OF FARNESYL DIPHOSPHATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN FARNESYLTRANSFERASE, ALPHA SUBUNIT; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: ALPHA SUBUNIT; COMPND 5 SYNONYM: CAAX FARNESYLTRANSFERASE ALPHA SUBUNIT; RAS PROTEINS COMPND 6 PRENYLTRANSFERASE ALPHA; FTASE-ALPHA; PRENYL-PROTEIN TRANSFERASE RAM2 COMPND 7 HOMOLOG; COMPND 8 EC: 2.5.1.-; COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: PROTEIN FARNESYLTRANSFERASE, BETA SUBUNIT; COMPND 12 CHAIN: B; COMPND 13 FRAGMENT: BETA SUBUNIT; COMPND 14 SYNONYM: CAAX FARNESYLTRANSFERASE BETA SUBUNIT; RAS PROTEINS COMPND 15 PRENYLTRANSFERASE BETA; FTASE-BETA; PRENYL-PROTEIN TRANSFERASE COMPND 16 DPR1/RAM1 SUBUNIT; COMPND 17 EC: 2.5.1.-; COMPND 18 ENGINEERED: YES; COMPND 19 MOL_ID: 3; COMPND 20 MOLECULE: SYNTHETIC HEXAPEPTIDE TKCVFM; COMPND 21 CHAIN: C; COMPND 22 ENGINEERED: YES; COMPND 23 OTHER_DETAILS: NON-SUBSTRATE INHIBITOR SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: NORWAY RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_ATCC_NUMBER: 63134; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 11 ORGANISM_COMMON: NORWAY RAT; SOURCE 12 ORGANISM_TAXID: 10116; SOURCE 13 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 14 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 16 EXPRESSION_SYSTEM_ATCC_NUMBER: 63134; SOURCE 17 MOL_ID: 3; SOURCE 18 SYNTHETIC: YES KEYWDS FTASE, PFT, PFTASE, FT, FPT, FARNESYLTRANSFERASE, FARNESYL KEYWDS 2 TRANSFERASE, FARNESYL PROTEIN TRANSFERASE, CAAX, RAS, CANCER, KEYWDS 3 INHIBITOR, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.B.LONG,P.J.CASEY,L.S.BEESE REVDAT 3 13-JUL-11 1JCS 1 VERSN REVDAT 2 24-FEB-09 1JCS 1 VERSN REVDAT 1 02-NOV-01 1JCS 0 JRNL AUTH S.B.LONG,P.J.HANCOCK,A.M.KRAL,H.W.HELLINGA,L.S.BEESE JRNL TITL THE CRYSTAL STRUCTURE OF HUMAN PROTEIN FARNESYLTRANSFERASE JRNL TITL 2 REVEALS THE BASIS FOR INHIBITION BY CAAX TETRAPEPTIDES AND JRNL TITL 3 THEIR MIMETICS. JRNL REF PROC.NATL.ACAD.SCI.USA V. 98 12948 2001 JRNL REFN ISSN 0027-8424 JRNL PMID 11687658 JRNL DOI 10.1073/PNAS.241407898 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.B.LONG,P.J.CASEY,L.S.BEESE REMARK 1 TITL THE BASIS FOR K-RAS4B BINDING SPECIFICITY TO PROTEIN REMARK 1 TITL 2 FARNESYLTRANSFERASE REVEALED BY 2A RESOLUTION TERNARY REMARK 1 TITL 3 COMPLEX STRUCTURES REMARK 1 REF STRUCTURE V. 8 209 2000 REMARK 1 REFN ISSN 0969-2126 REMARK 1 DOI 10.1016/S0969-2126(00)00096-4 REMARK 1 REFERENCE 2 REMARK 1 AUTH H.-W.PARK,S.R.BODULURI,J.F.MOOMAW,P.J.CASEY,L.S.BEESE REMARK 1 TITL CRYSTAL STRUCTURE OF PROTEIN FARNESYLTRANSFERASE AT 2.25A REMARK 1 TITL 2 RESOLUTION REMARK 1 REF SCIENCE V. 275 1800 1997 REMARK 1 REFN ISSN 0036-8075 REMARK 1 DOI 10.1126/SCIENCE.275.5307.1800 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 89.7 REMARK 3 NUMBER OF REFLECTIONS : 52877 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : FROM PDB ENTRY 1D8D REMARK 3 R VALUE (WORKING SET) : 0.160 REMARK 3 FREE R VALUE : 0.202 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2633 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.30 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 76.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5326 REMARK 3 BIN R VALUE (WORKING SET) : 0.2370 REMARK 3 BIN FREE R VALUE : 0.2550 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 285 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.015 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5997 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 436 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 31.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.65200 REMARK 3 B22 (A**2) : -1.65200 REMARK 3 B33 (A**2) : 8.14300 REMARK 3 B12 (A**2) : 0.29400 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.21 REMARK 3 ESD FROM SIGMAA (A) : 0.25 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.26 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.26 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.30 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.32 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.030 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.180 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.780 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 5.630 ; 2.500 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARHCSDX.PR REMARK 3 PARAMETER FILE 2 : PARAM19.SOL REMARK 3 PARAMETER FILE 3 : ACE REMARK 3 PARAMETER FILE 4 : FPP REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PR REMARK 3 TOPOLOGY FILE 2 : TOPH19.SOL REMARK 3 TOPOLOGY FILE 3 : ACE REMARK 3 TOPOLOGY FILE 4 : FPP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 1JCS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-JUN-01. REMARK 100 THE RCSB ID CODE IS RCSB013632. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-MAY-99 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 55202 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.8 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.23 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.98 REMARK 200 R MERGE FOR SHELL (I) : 0.26900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.640 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: PDB ENTRY 1D8D REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.67 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, AMMONIUM ACETATE, DTT, TRIS- REMARK 280 HCL, PH 5.7, VAPOR DIFFUSION, HANGING DROP AT 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 23.14167 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 46.28333 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 34.71250 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 57.85417 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 11.57083 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL UNIT OF PROTEIN FARNESYLTRANSFERASE (FTASE) REMARK 300 IS A HETERODIMER OF ALPHA AND BETA SUBUNITS. THERE IS ONE FTASE REMARK 300 HETERODIMER PER ASYMMETRIC UNIT. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8990 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29380 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -66.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ALA A 3 REMARK 465 THR A 4 REMARK 465 GLU A 5 REMARK 465 GLY A 6 REMARK 465 VAL A 7 REMARK 465 GLY A 8 REMARK 465 GLU A 9 REMARK 465 SER A 10 REMARK 465 ALA A 11 REMARK 465 PRO A 12 REMARK 465 GLY A 13 REMARK 465 GLY A 14 REMARK 465 GLU A 15 REMARK 465 PRO A 16 REMARK 465 GLY A 17 REMARK 465 GLN A 18 REMARK 465 PRO A 19 REMARK 465 GLU A 20 REMARK 465 GLN A 21 REMARK 465 PRO A 22 REMARK 465 PRO A 23 REMARK 465 PRO A 24 REMARK 465 PRO A 25 REMARK 465 PRO A 26 REMARK 465 PRO A 27 REMARK 465 PRO A 28 REMARK 465 PRO A 29 REMARK 465 PRO A 30 REMARK 465 ALA A 31 REMARK 465 GLN A 32 REMARK 465 GLN A 33 REMARK 465 PRO A 34 REMARK 465 GLN A 35 REMARK 465 GLU A 36 REMARK 465 GLU A 37 REMARK 465 GLU A 38 REMARK 465 MET A 39 REMARK 465 ALA A 40 REMARK 465 ALA A 41 REMARK 465 GLU A 42 REMARK 465 ALA A 43 REMARK 465 GLY A 44 REMARK 465 GLU A 45 REMARK 465 ALA A 46 REMARK 465 ALA A 47 REMARK 465 ALA A 48 REMARK 465 SER A 49 REMARK 465 PRO A 50 REMARK 465 MET A 51 REMARK 465 ASP A 52 REMARK 465 ASP A 53 REMARK 465 GLY A 54 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 SER B 3 REMARK 465 SER B 4 REMARK 465 SER B 5 REMARK 465 SER B 6 REMARK 465 PHE B 7 REMARK 465 THR B 8 REMARK 465 TYR B 9 REMARK 465 TYR B 10 REMARK 465 CYS B 11 REMARK 465 PRO B 12 REMARK 465 PRO B 13 REMARK 465 SER B 14 REMARK 465 SER B 15 REMARK 465 SER B 16 REMARK 465 GLU B 424 REMARK 465 GLU B 425 REMARK 465 CYS B 426 REMARK 465 GLU B 427 REMARK 465 ASP B 428 REMARK 465 ALA B 429 REMARK 465 VAL B 430 REMARK 465 THR B 431 REMARK 465 SER B 432 REMARK 465 ASP B 433 REMARK 465 PRO B 434 REMARK 465 ALA B 435 REMARK 465 THR B 436 REMARK 465 ASP B 437 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU B 308 CA - CB - CG ANGL. DEV. = -15.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 71 0.49 -59.33 REMARK 500 ASN A 127 87.83 -157.60 REMARK 500 LEU A 215 53.75 -106.72 REMARK 500 THR A 247 -86.85 -111.94 REMARK 500 ASP A 252 107.42 -58.04 REMARK 500 PRO A 304 -81.77 -60.25 REMARK 500 HIS A 306 23.19 -146.79 REMARK 500 ASN A 325 50.32 -108.77 REMARK 500 GLN A 326 71.44 26.82 REMARK 500 GLU A 347 -60.81 -133.26 REMARK 500 ASP A 349 55.62 -157.97 REMARK 500 GLN B 74 65.63 -67.68 REMARK 500 SER B 99 31.49 -144.43 REMARK 500 ASN B 234 -169.47 -115.12 REMARK 500 MET B 329 48.32 -81.22 REMARK 500 PRO B 421 131.11 -38.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 GLU A 185 24.6 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1477 DISTANCE = 5.75 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B1001 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 362 NE2 REMARK 620 2 CYS B 299 SG 117.2 REMARK 620 3 CYS C 3 SG 103.8 117.2 REMARK 620 4 ASP B 297 OD1 83.0 88.3 144.6 REMARK 620 5 ASP B 297 OD2 117.6 106.3 92.5 55.1 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FII B 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACY B 3002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACY B 3003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF SYNTHETIC REMARK 800 HEXAPEPTIDE TKCVFM REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1D8D RELATED DB: PDB REMARK 900 PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH A K-RAS4B REMARK 900 PEPTIDE SUBSTRATE AND FARNESYL DIPHOSPHATE ANALOG REMARK 900 RELATED ID: 1FT1 RELATED DB: PDB REMARK 900 UNLIGANDED PROTEIN FARENESYLTRANSFERASE REMARK 900 RELATED ID: 1JCQ RELATED DB: PDB REMARK 900 HUMAN PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH FARNESYL REMARK 900 DIPHOSPHATE AND THE PEPTIDOMIMETIC INHIBITOR L-739,750 REMARK 900 RELATED ID: 1JCR RELATED DB: PDB REMARK 900 RAT PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH THE NON- REMARK 900 SUBSTRATE TETRAPEPTIDE INHIBITOR CVFM AND FARNESYL REMARK 900 DIPHOSPHATE SUBSTRATE DBREF 1JCS A 1 377 UNP Q04631 PFTA_RAT 1 377 DBREF 1JCS B 1 437 UNP Q02293 PFTB_RAT 1 437 DBREF 1JCS C 1 6 PDB 1JCS 1JCS 1 6 SEQRES 1 A 377 MET ALA ALA THR GLU GLY VAL GLY GLU SER ALA PRO GLY SEQRES 2 A 377 GLY GLU PRO GLY GLN PRO GLU GLN PRO PRO PRO PRO PRO SEQRES 3 A 377 PRO PRO PRO PRO ALA GLN GLN PRO GLN GLU GLU GLU MET SEQRES 4 A 377 ALA ALA GLU ALA GLY GLU ALA ALA ALA SER PRO MET ASP SEQRES 5 A 377 ASP GLY PHE LEU SER LEU ASP SER PRO THR TYR VAL LEU SEQRES 6 A 377 TYR ARG ASP ARG ALA GLU TRP ALA ASP ILE ASP PRO VAL SEQRES 7 A 377 PRO GLN ASN ASP GLY PRO SER PRO VAL VAL GLN ILE ILE SEQRES 8 A 377 TYR SER GLU LYS PHE ARG ASP VAL TYR ASP TYR PHE ARG SEQRES 9 A 377 ALA VAL LEU GLN ARG ASP GLU ARG SER GLU ARG ALA PHE SEQRES 10 A 377 LYS LEU THR ARG ASP ALA ILE GLU LEU ASN ALA ALA ASN SEQRES 11 A 377 TYR THR VAL TRP HIS PHE ARG ARG VAL LEU LEU ARG SER SEQRES 12 A 377 LEU GLN LYS ASP LEU GLN GLU GLU MET ASN TYR ILE ILE SEQRES 13 A 377 ALA ILE ILE GLU GLU GLN PRO LYS ASN TYR GLN VAL TRP SEQRES 14 A 377 HIS HIS ARG ARG VAL LEU VAL GLU TRP LEU LYS ASP PRO SEQRES 15 A 377 SER GLN GLU LEU GLU PHE ILE ALA ASP ILE LEU ASN GLN SEQRES 16 A 377 ASP ALA LYS ASN TYR HIS ALA TRP GLN HIS ARG GLN TRP SEQRES 17 A 377 VAL ILE GLN GLU PHE ARG LEU TRP ASP ASN GLU LEU GLN SEQRES 18 A 377 TYR VAL ASP GLN LEU LEU LYS GLU ASP VAL ARG ASN ASN SEQRES 19 A 377 SER VAL TRP ASN GLN ARG HIS PHE VAL ILE SER ASN THR SEQRES 20 A 377 THR GLY TYR SER ASP ARG ALA VAL LEU GLU ARG GLU VAL SEQRES 21 A 377 GLN TYR THR LEU GLU MET ILE LYS LEU VAL PRO HIS ASN SEQRES 22 A 377 GLU SER ALA TRP ASN TYR LEU LYS GLY ILE LEU GLN ASP SEQRES 23 A 377 ARG GLY LEU SER ARG TYR PRO ASN LEU LEU ASN GLN LEU SEQRES 24 A 377 LEU ASP LEU GLN PRO SER HIS SER SER PRO TYR LEU ILE SEQRES 25 A 377 ALA PHE LEU VAL ASP ILE TYR GLU ASP MET LEU GLU ASN SEQRES 26 A 377 GLN CYS ASP ASN LYS GLU ASP ILE LEU ASN LYS ALA LEU SEQRES 27 A 377 GLU LEU CYS GLU ILE LEU ALA LYS GLU LYS ASP THR ILE SEQRES 28 A 377 ARG LYS GLU TYR TRP ARG TYR ILE GLY ARG SER LEU GLN SEQRES 29 A 377 SER LYS HIS SER ARG GLU SER ASP ILE PRO ALA SER VAL SEQRES 1 B 437 MET ALA SER SER SER SER PHE THR TYR TYR CYS PRO PRO SEQRES 2 B 437 SER SER SER PRO VAL TRP SER GLU PRO LEU TYR SER LEU SEQRES 3 B 437 ARG PRO GLU HIS ALA ARG GLU ARG LEU GLN ASP ASP SER SEQRES 4 B 437 VAL GLU THR VAL THR SER ILE GLU GLN ALA LYS VAL GLU SEQRES 5 B 437 GLU LYS ILE GLN GLU VAL PHE SER SER TYR LYS PHE ASN SEQRES 6 B 437 HIS LEU VAL PRO ARG LEU VAL LEU GLN ARG GLU LYS HIS SEQRES 7 B 437 PHE HIS TYR LEU LYS ARG GLY LEU ARG GLN LEU THR ASP SEQRES 8 B 437 ALA TYR GLU CYS LEU ASP ALA SER ARG PRO TRP LEU CYS SEQRES 9 B 437 TYR TRP ILE LEU HIS SER LEU GLU LEU LEU ASP GLU PRO SEQRES 10 B 437 ILE PRO GLN ILE VAL ALA THR ASP VAL CYS GLN PHE LEU SEQRES 11 B 437 GLU LEU CYS GLN SER PRO ASP GLY GLY PHE GLY GLY GLY SEQRES 12 B 437 PRO GLY GLN TYR PRO HIS LEU ALA PRO THR TYR ALA ALA SEQRES 13 B 437 VAL ASN ALA LEU CYS ILE ILE GLY THR GLU GLU ALA TYR SEQRES 14 B 437 ASN VAL ILE ASN ARG GLU LYS LEU LEU GLN TYR LEU TYR SEQRES 15 B 437 SER LEU LYS GLN PRO ASP GLY SER PHE LEU MET HIS VAL SEQRES 16 B 437 GLY GLY GLU VAL ASP VAL ARG SER ALA TYR CYS ALA ALA SEQRES 17 B 437 SER VAL ALA SER LEU THR ASN ILE ILE THR PRO ASP LEU SEQRES 18 B 437 PHE GLU GLY THR ALA GLU TRP ILE ALA ARG CYS GLN ASN SEQRES 19 B 437 TRP GLU GLY GLY ILE GLY GLY VAL PRO GLY MET GLU ALA SEQRES 20 B 437 HIS GLY GLY TYR THR PHE CYS GLY LEU ALA ALA LEU VAL SEQRES 21 B 437 ILE LEU LYS LYS GLU ARG SER LEU ASN LEU LYS SER LEU SEQRES 22 B 437 LEU GLN TRP VAL THR SER ARG GLN MET ARG PHE GLU GLY SEQRES 23 B 437 GLY PHE GLN GLY ARG CYS ASN LYS LEU VAL ASP GLY CYS SEQRES 24 B 437 TYR SER PHE TRP GLN ALA GLY LEU LEU PRO LEU LEU HIS SEQRES 25 B 437 ARG ALA LEU HIS ALA GLN GLY ASP PRO ALA LEU SER MET SEQRES 26 B 437 SER HIS TRP MET PHE HIS GLN GLN ALA LEU GLN GLU TYR SEQRES 27 B 437 ILE LEU MET CYS CYS GLN CYS PRO ALA GLY GLY LEU LEU SEQRES 28 B 437 ASP LYS PRO GLY LYS SER ARG ASP PHE TYR HIS THR CYS SEQRES 29 B 437 TYR CYS LEU SER GLY LEU SER ILE ALA GLN HIS PHE GLY SEQRES 30 B 437 SER GLY ALA MET LEU HIS ASP VAL VAL MET GLY VAL PRO SEQRES 31 B 437 GLU ASN VAL LEU GLN PRO THR HIS PRO VAL TYR ASN ILE SEQRES 32 B 437 GLY PRO ASP LYS VAL ILE GLN ALA THR THR HIS PHE LEU SEQRES 33 B 437 GLN LYS PRO VAL PRO GLY PHE GLU GLU CYS GLU ASP ALA SEQRES 34 B 437 VAL THR SER ASP PRO ALA THR ASP SEQRES 1 C 6 THR LYS CYS VAL PHE MET HET ZN B1001 1 HET FII B1002 24 HET ACY B3002 4 HET ACY B3003 4 HETNAM ZN ZINC ION HETNAM FII [(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)- HETNAM 2 FII METHYL]-PHOSPHONIC ACID HETNAM ACY ACETIC ACID HETSYN FII FPP ANALOG FORMUL 4 ZN ZN 2+ FORMUL 5 FII C17 H30 N O5 P FORMUL 6 ACY 2(C2 H4 O2) FORMUL 8 HOH *436(H2 O) HELIX 1 1 LEU A 65 ARG A 69 5 5 HELIX 2 2 ARG A 69 ALA A 73 5 5 HELIX 3 3 SER A 93 ASP A 110 1 18 HELIX 4 4 SER A 113 ASN A 127 1 15 HELIX 5 5 ASN A 130 LEU A 144 1 15 HELIX 6 6 ASP A 147 GLN A 162 1 16 HELIX 7 7 ASN A 165 LYS A 180 1 16 HELIX 8 8 GLN A 184 ASP A 196 1 13 HELIX 9 9 ASN A 199 ARG A 214 1 16 HELIX 10 10 ASN A 218 ASP A 230 1 13 HELIX 11 11 ASN A 233 THR A 247 1 15 HELIX 12 12 ASP A 252 VAL A 270 1 19 HELIX 13 13 ASN A 273 GLN A 285 1 13 HELIX 14 14 GLY A 288 ARG A 291 5 4 HELIX 15 15 TYR A 292 ASP A 301 1 10 HELIX 16 16 LEU A 302 SER A 307 1 6 HELIX 17 17 SER A 308 ASN A 325 1 18 HELIX 18 18 ASN A 329 GLU A 347 1 19 HELIX 19 19 ASP A 349 ILE A 351 5 3 HELIX 20 20 ARG A 352 SER A 368 1 17 HELIX 21 21 ARG A 369 ILE A 373 5 5 HELIX 22 22 LEU B 23 ARG B 27 5 5 HELIX 23 23 ARG B 27 ARG B 34 5 8 HELIX 24 24 THR B 42 HIS B 66 1 25 HELIX 25 25 GLN B 74 LEU B 86 1 13 HELIX 26 26 THR B 90 ASP B 97 5 8 HELIX 27 27 SER B 99 LEU B 114 1 16 HELIX 28 28 PRO B 119 GLN B 134 1 16 HELIX 29 29 HIS B 149 GLY B 164 1 16 HELIX 30 30 THR B 165 ILE B 172 1 8 HELIX 31 31 ASN B 173 LYS B 185 1 13 HELIX 32 32 ASP B 200 THR B 214 1 15 HELIX 33 33 GLY B 224 CYS B 232 1 9 HELIX 34 34 HIS B 248 LYS B 263 1 16 HELIX 35 35 LYS B 264 LEU B 268 5 5 HELIX 36 36 ASN B 269 SER B 279 1 11 HELIX 37 37 CYS B 299 GLN B 304 1 6 HELIX 38 38 GLY B 306 GLN B 318 1 13 HELIX 39 39 HIS B 331 CYS B 343 1 13 HELIX 40 40 ASP B 359 GLN B 374 1 16 HELIX 41 41 VAL B 389 VAL B 393 5 5 HELIX 42 42 GLY B 404 LEU B 416 1 13 SHEET 1 A 2 GLN A 89 ILE A 90 0 SHEET 2 A 2 GLN B 88 LEU B 89 1 N LEU B 89 O GLN A 89 SHEET 1 B 2 HIS B 375 SER B 378 0 SHEET 2 B 2 MET B 381 ASP B 384 -1 O MET B 381 N SER B 378 LINK ZN ZN B1001 NE2 HIS B 362 1555 1555 2.17 LINK ZN ZN B1001 SG CYS B 299 1555 1555 2.21 LINK ZN ZN B1001 SG CYS C 3 1555 1555 2.35 LINK ZN ZN B1001 OD1 ASP B 297 1555 1555 2.55 LINK ZN ZN B1001 OD2 ASP B 297 1555 1555 2.08 SITE 1 AC1 4 ASP B 297 CYS B 299 HIS B 362 CYS C 3 SITE 1 AC2 19 TYR A 166 TYR A 200 TYR B 205 HIS B 248 SITE 2 AC2 19 GLY B 250 CYS B 254 ARG B 291 LYS B 294 SITE 3 AC2 19 TYR B 300 TRP B 303 TYR B 361 HOH B1162 SITE 4 AC2 19 HOH B1164 HOH B1165 HOH B1168 HOH B1198 SITE 5 AC2 19 VAL C 4 PHE C 5 HOH C1253 SITE 1 AC3 5 LEU B 89 THR B 90 TYR B 93 HOH B1183 SITE 2 AC3 5 ACY B3003 SITE 1 AC4 5 TYR B 81 TYR B 93 ARG B 358 ASP B 359 SITE 2 AC4 5 ACY B3002 SITE 1 AC5 24 LYS A 164 TYR A 166 GLN A 167 HOH A1167 SITE 2 AC5 24 HOH A1310 ALA B 98 SER B 99 TRP B 102 SITE 3 AC5 24 TRP B 106 ARG B 202 ASP B 297 LYS B 356 SITE 4 AC5 24 TYR B 361 HIS B 362 ZN B1001 FII B1002 SITE 5 AC5 24 HOH B1163 HOH C1184 HOH C1246 HOH C1253 SITE 6 AC5 24 HOH C1317 HOH C1318 HOH C1412 HOH C1568 CRYST1 170.921 170.921 69.425 90.00 90.00 120.00 P 61 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005851 0.003378 0.000000 0.00000 SCALE2 0.000000 0.006756 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014404 0.00000